Radiation Therapy Oncology Group 0521: A phase III randomized trial of androgen suppression and radiation therapy versus androgen suppression and radiation therapy followed by chemotherapy with docetaxel/prednisone for localized, high-risk prostate cancer

Asmita R. Patel, Howard M. Sandler, Kenneth J. Pienta

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)212-214
Number of pages3
JournalClinical Genitourinary Cancer
Volume4
Issue number3
DOIs
StatePublished - Dec 2005
Externally publishedYes

Keywords

  • Hormone-naive disease
  • Intensity-modulated radiation therapy
  • Locally advanced disease

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this